Skip to content

TRAVERE THERAPEUTICS, INC.: 10-K filed 2015-03-11

What TRAVERE THERAPEUTICS, INC. reported in its annual report filed 2015-03-11 (fiscal FY 2014): 41 published measures, 144 facts as tagged in accession 0001571049-15-001817.

This filing

Form
10-K (annual report)
Filed
2015-03-11
Fiscal period
fiscal FY 2014
Accession
0001571049-15-001817 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TRAVERE THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-12-31135,470,972USD
At 2013-12-3120,498,879USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-12-31172,721,691USD
At 2013-12-3140,165,777USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-12-31-37,250,719USD
At 2013-12-31-19,666,898USD
At 2012-12-31-3,407,815USD
At 2011-12-31-536,285USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-12-3118,204,282USD
At 2013-12-315,997,307USD
At 2012-12-3111,388USD
At 2011-12-3110,053USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-10-03 to 2014-12-31-29,027,160USD90
2014-01-01 to 2014-12-31-110,937,862USD365
2014-07-01 to 2014-09-30-17,979,793USD92
2014-04-01 to 2014-06-3011,804,738USD91
2014-01-01 to 2014-03-31-75,735,647USD90
2013-10-02 to 2013-12-31-12,822,275USD91
2013-01-01 to 2013-12-31-34,624,884USD365
2013-07-01 to 2013-09-30-12,011,174USD92
2013-04-01 to 2013-06-30-4,923,513USD91
2013-01-01 to 2013-03-31-4,867,922USD90
2012-01-01 to 2012-12-31-30,343,856USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-12-31662,597USD365
2013-01-01 to 2013-12-31117,033USD365
2012-01-01 to 2012-12-3124,774USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2014-01-01 to 2014-12-3195,319,453USD365
2013-01-01 to 2013-12-3128,981,512USD365
2012-01-01 to 2012-12-314,437,667USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-12-31-179,174,858USD
At 2013-12-31-68,236,996USD

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-10-03 to 2014-12-31-1.1USD/shares90
2014-07-01 to 2014-09-30-0.67USD/shares92
2014-04-01 to 2014-06-300.46USD/shares91
2014-01-01 to 2014-03-31-3.25USD/shares90

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-10-03 to 2014-12-31-1.1USD/shares90
2014-07-01 to 2014-09-30-0.83USD/shares92
2014-04-01 to 2014-06-30-0.77USD/shares91
2014-01-01 to 2014-03-31-3.25USD/shares90

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-2,459,748USD365
2014-04-01 to 2014-06-30-2,525,124USD91
2014-01-01 to 2014-03-3165,376USD90
2013-10-02 to 2013-12-3175,775USD91
2013-01-01 to 2013-12-3175,775USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-12-31670,796USD
At 2013-12-31127,427USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-12-3116,638,766USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-10-03 to 2014-12-31-18,697,060USD90
2014-01-01 to 2014-12-31-79,807,693USD365
2014-07-01 to 2014-09-30-21,867,032USD92
2014-04-01 to 2014-06-30-17,181,932USD91
2014-01-01 to 2014-03-31-22,061,669USD90
2013-10-02 to 2013-12-31-11,872,201USD91
2013-01-01 to 2013-12-31-24,773,448USD365
2013-07-01 to 2013-09-30-6,030,861USD92
2013-04-01 to 2013-06-30-4,984,902USD91
2013-01-01 to 2013-03-31-1,885,484USD90
2012-01-01 to 2012-12-31-30,257,017USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-12-3137,333,662USD
At 2013-12-317,501,244USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-01-01 to 2014-12-317,434,878USD365
2014-07-01 to 2014-09-302,600,000USD92
2014-01-01 to 2014-09-304,800,000USD273
2013-01-01 to 2013-12-3146,344USD365
2013-07-01 to 2013-09-300USD92
2013-01-01 to 2013-09-3041,554USD273
2012-01-01 to 2012-12-3184,087USD366

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-12-31107,538,551USD
At 2013-12-3136,564,878USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-12-317,124,330USD
At 2013-12-313,553,567USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2014-12-31935,935USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2014-12-3194,265,530USD
At 2013-12-3112,586,150USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-12-317,959,411USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2014-01-01 to 2014-12-312,257,336USD365
2013-01-01 to 2013-12-31957,272USD365

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-10-03 to 2014-12-3132,782,048USD90
2014-01-01 to 2014-12-31108,010,898USD365
2014-07-01 to 2014-09-3030,215,615USD92
2014-04-01 to 2014-06-3022,923,666USD91
2014-01-01 to 2014-03-3122,089,569USD90
2013-10-02 to 2013-12-3111,872,201USD91
2013-01-01 to 2013-12-3124,773,448USD365
2013-07-01 to 2013-09-306,030,861USD92
2013-04-01 to 2013-06-304,984,902USD91
2013-01-01 to 2013-03-311,885,484USD90
2012-01-01 to 2012-12-3130,257,017USD366

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-12-31800,507USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2014-01-01 to 2014-12-3159,644,696USD365
2013-01-01 to 2013-12-3117,689,439USD365
2012-01-01 to 2012-12-3129,594,515USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-01-01 to 2014-12-3147,795,223USD365
2013-01-01 to 2013-12-317,084,009USD365
2012-01-01 to 2012-12-31662,502USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-12-3126,048,480shares
At 2013-12-3118,415,573shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-12-31140,850,551USD
At 2013-12-3149,635,502USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-12-314,285,553USD
At 2013-12-31-109,987USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-12-311,888,035USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-12-3112,234,513USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2014-12-3127,882,995USD
At 2013-12-314,881,434USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2014-12-31813,364USD
At 2013-12-311,370,943USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2014-10-03 to 2014-12-31-29,027,160USD90
2014-01-01 to 2014-12-31-113,397,610USD365
2014-07-01 to 2014-09-30-17,979,793USD92
2014-04-01 to 2014-06-309,279,614USD91
2014-01-01 to 2014-03-31-75,670,271USD90
2013-10-02 to 2013-12-31-12,746,500USD91
2013-01-01 to 2013-12-31-34,549,109USD365
2013-07-01 to 2013-09-30-12,011,174USD92
2013-04-01 to 2013-06-30-4,923,513USD91
2013-01-01 to 2013-03-31-4,867,922USD90
2012-01-01 to 2012-12-31-30,343,856USD366

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-106,542,322USD365
2013-01-01 to 2013-12-31-34,734,871USD365
2012-01-01 to 2012-12-31-30,343,856USD366

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2014-01-01 to 2014-12-315,401,038USD365
2013-01-01 to 2013-12-31215,993USD365
2012-01-01 to 2012-12-31124,885USD366

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2014-10-03 to 2014-12-31-10,330,100USD90
2014-01-01 to 2014-12-31-33,589,917USD365
2014-07-01 to 2014-09-303,887,239USD92
2014-04-01 to 2014-06-3026,461,546USD91
2014-01-01 to 2014-03-31-53,608,602USD90
2013-10-02 to 2013-12-31-874,299USD91
2013-01-01 to 2013-12-31-9,775,661USD365
2013-07-01 to 2013-09-30-5,980,313USD92
2013-04-01 to 2013-06-3061,389USD91
2013-01-01 to 2013-03-31-2,982,438USD90
2012-01-01 to 2012-12-31-86,839USD366

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-2,459USD365
2013-01-01 to 2013-12-31-9,728USD365
2012-01-01 to 2012-12-31-1,906USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2014-01-01 to 2014-12-3140,000,000USD365
2014-01-01 to 2014-01-0936,800,000USD9
2013-01-01 to 2013-12-3130,936,748USD365
2012-01-01 to 2012-12-313,475,703USD366

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-12-317,959,411USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-12-31282,502USD365

Inspect the source

Entity
TRAVERE THERAPEUTICS, INC. / CIK 0001438533
Captured
2026-09-20T09:03:46.664Z
SEC response SHA-256
b66a9ecfb78fb2c3fc29384fc9ee702340e57ee037364236a402186d866938b6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001438533.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))